Home | Provider Manual Home | Contributors | Technical Information
Preface | Note to Users | Feedback | Disclaimer
search CALS Provider Manual
Collapse All  |  Expand All
  • Volume I:
    First Thirty Minutes
    • Section 1
      Acute Care Algorithm/ Treatment Plans/ Acronyms
      • CALS Approach
        • CALS Universal Approach
        • Patient Transport
      • Airway
        • Rapid Sequence Intubation Algorithm/Rescue Airways
        • Endotracheal Intubation FlowSheet
        • Rapid Sequence Intubation Medications
        • Rapid Sequence Intubation Drug Calculator
        • Rapid Sequence Intubation Dosage Chart
        • Obstructed Airway Algorithm Adult and Pediatric
        • Initial Laboratory Studies
      • Cardiovascular
        • CPR Steps for Adults, Children, and Infants
        • Automated External Defibrillator Algorithm
        • Ventricular Fibrillation-Pulseless Ventricular Tachycardia Algorithm
        • Pulseless Electrical Activity Algorithm-Adult and Peds
        • Asystole Algorithm-Adult and Peds
        • Bradycardia Algorithm
        • Tachycardia Algorithm
        • Atrial Fibrillation/Atrial Flutter Algorithm
        • Electrical Cardioversion Algorithm-Adult and Pediatric
        • Chest Pain Evaluation Algorithm
      • Emergency Preparedness
        • Therapeutic Hypothermia
        • Mobilization Checklist
        • Symptom Recognition-Therapy
        • Blast Injuries
      • Fluids & Electrolytes
        • Causes of Anion and Non-Anion Gap Acidosis
      • Infection
        • Sepsis Guidelines
      • Neonatal
        • Neonatal Resuscitation Algorithm
        • Inverted Triangle-APGAR Score
        • Drugs in Neonatal Resuscitation Algorithm
      • Neurology
        • Altered Level of Consciousness
        • Glasgow Coma Scale-Adult, Peds,Infant
        • Tips From the Vowels Acronym
        • NIH Stroke Scale (Abbreviated)
        • Status Epilepticus Treatment Plan
      • Obstetrics
        • Postpartum Hemorrhage Algorithm
        • Shoulder Dystocia—HELPERR
        • Vacuum Delivery Acronym-ABCDEFGHIJ
      • Ophthalmology
        • Central Retinal Artery Occlusion
        • Chemical Burn Exposure to Eye
      • Pediatrics
        • Pediatric Equipment Sizes
        • Modified Lund Browder Chart
      • Trauma
        • Shock Acronym-Shrimpcan
        • Burn Management Treatment Plan
        • Initial Care of Major Trauma
        • Trauma Flow Sheet
    • Section 2
      Universal Approach
      • CALS Universal Approach To Emergency Advanced Life Support
    • Section 3
      Steps 1-6
      • Steps 1-6
      • Step 1: Activate the Team
      • Step 2: Immediate Control and Immobilization
      • Step 3: Initial Survey
      • Step 3: Simultaneous Team Action By Team Members
      • Step 4: Preliminary Clinical Impression
      • Step 5: Working Diagnosis and Disposition
      • Step 6: Team Process and Review
    • Section 4
      Preliminary Impression/Focused Clinical Pathways
      • Pathway 1: Altered Level of Consciousness (Adult and Pediatric)
      • Pathway 2: Cardiovascular Emergencies (Adult and Pediatric)
      • Pathway 3: Gastrointestinal/Abdominal Emergencies (Adult and Pediatric)
      • Pathway 4: Neonatal Emergencies
      • Pathway 5: Obstetrical Emergencies
      • Pathway 6: Adult Respiratory
      • Pathway 7: Pediatric Respiratory
      • Pathway 8: Adult Trauma (Secondary Survey for Adults)
      • Pathway 9: Pediatric Trauma (Secondary Survey for Trauma in Children)
  • Volume II:
    Resuscitation Procedures
    • Section 5
      Airway Skills
      • Airway Skills 1: Aids to Intubation
      • Airway Skills 2: Bag-Valve-Mask Use
      • Airway Skills 3: Orotracheal Intubation
      • Airway Skills 4: Rapid Sequence Intubation
      • Airway Skills 5: Cricoid Pressure and the BURP Technique
      • Airway Skills 6: Esophageal Tracheal Combitube
      • Airway Skills 7: King Airway
      • Airway Skills 8: Intubating Laryngeal Mask Airway
      • Airway Skills 9: Nasotracheal Intubation
      • Airway Skills 10: Topical Anesthesia
      • Airway Skills 11: Retrograde Intubation
      • Airway Skills 12: Tracheal Foreign Body Removal
      • Airway Skills 13: Cricothyrotomy
      • Airway Skills 14: Tracheotomy
      • Airway Skills 15: Tracheotomy in Infants
      • Airway Skills 16: Transtracheal Needle Ventilation
    • Section 6
      Breathing Skills
      • Section 6 Breathing Skills Portals
      • Breathing Skills 1: Chest Tube Insertion
      • Breathing Skills 2: Chest Suction and Autotransfusion
      • Breathing Skills 3: Endobronchial Tube
      • Breathing Skills 4: Heliox
      • Breathing Skills 5: Needle Thoracostomy
    • Section 7
      Circulation Skills
      • Section 7 Circulation Skills Portals
      • Circulation Skills 1: Arterial and Venous Catheter Insertion
      • Circulation Skills 2: Central Venous Access
      • Circulation Skills 3: Central Venous Pressure Measurement
      • Circulation Skills 4: Emergency Thoracotomy
      • Circulation Skills 5: Intraosseous Needle Placement (Adult)
      • Circulation Skills 6: Pericardiocentesis
      • Circulation Skills 7: Rewarming Techniques
      • Circulation Skills 8: Saphenous Vein Cutdown
      • Circulation Skills 9: Transvenous Cardiac Pacing
    • Section 8
      Disability Skills
      • Section 8 Disability Skills Portals
      • Disability Skills 1: Skull Trephination
      • Disability Skills 2: Raney Scalp Clips
    • Section 9
      Trauma Skills
      • Trauma Skills Portals
      • Trauma Skills 1: Compartment Pressure Measurement
      • Trauma Skills 2: Femur Fracture Splinting
      • Trauma Skills 3: Pelvic Fracture Stabilization
      • Trauma Skills 4: Suprapubic Cystostomy
    • Section 10
      X-Rays Skills
      • X-ray Skills 1: Cervical Spine Rules and Use of Imaging Portal
      • X-ray Skills 2: Cervical Spine X-ray Interpretation
      • Xray Skills 3: Interpretation of a Pelvic X-ray
  • Volume III:
    Definitive Care
    • Section 11
      Airway
      • Rapid Sequence Intubation Portal
      • Airway Obstruction Portal
      • Heliox Treatment Portal
      • Ventilator Management Portal
      • Noninvasive Ventilatory Support Portal
      • Inspiratory Impedance Threshold Device Portal
      • Status Asthmaticus Portal
      • Anaphylaxis Portal
    • Section 12
      Cardiovascular
      • Cardiovascular 1: Classification of Pharmacological (Therapeutic) Interventions Portal
      • Cardiovascular 2: Cardiac Rhythms Portal
      • Cardiovascular 3: Pharmacology of Cardiovascular Agents Portal
      • Cardiovascular 4: Endotracheal Drug Delivery
      • Cardiovascular 5: Ventricular Fibrillation/Pulseless Ventricular Tachycardia Portal
      • Cardiovascular 6: Pulseless Electrical Activity Portal
      • Cardiovascular 7: Asystole Treatment Portal
      • Cardiovascular 8: Tachycardia Treatment Portal
      • Cardiovascular 9: Electrical Cardioversion Portal
      • Cardiovascular 10: Bradycardia Treatment Portal
      • Cardiovascular 11: Acute Coronary Syndromes Portal (Acure Ischemic Chest Pain)
      • Cardiovascular 12: Acute Heart Failure Portal
      • Cardiovascular 13: Hypertensive Crises Portal
      • Cardiovascular 14: Digitalis Toxicity Portal
      • Cardiovascular 15: Long QT Syndrome Portal
      • Cardiovascular Diagnostic Treatment Portals
    • Section 13
      Emergency Preparedness
      • Emergency Preparedness 1: Community-Wide Collaboration Portal
      • Emergency Preparedness 2: Approaches to Planning
      • Emergency Preparedness 3: Hazard Vulnerability Analysis Portal
      • Emergency Preparedness 4: Incident Command System Portal
      • Emergency Preparedness 5: Emergency Management Program Portal
      • Emergency Preparedness 6: Basic All Hazards Response Portal
      • Emergency Preparedness 7: Rapid and Efficient Mobilization Portal
      • Emergency Preparedness 8: Emergency Event Response Classifications Portal
      • Emergency Preparedness 9: Triage Portal
      • Emergency Preparedness 10: Surge Capacity Planning and Scarce Resources Guidelines
      • Emergency Preparedness 11: Glossary of Terms
      • Emergency Preparedness 12: Resources
      • Emergency Preparedness 13: Introduction to Nuclear, Biological, and Chemical Warfare
      • Emergency Preparedness 14: Nuclear Devices Portal
      • Emergency Preparedness 15: Acute Radiation Syndrome Portal
      • Emergency Preparedness 16: Biological Agents Portal
      • Emergency Preparedness 17: Chemical Agents Portal
      • Emergency Preparedness 18: Explosion and Blast Injuries Portal
      • Emergency Preparedness 19: Patient Isolation Precautions
      • Emergency Preparedness 20: Additional References and Resources
    • Section 14
      Endocrine and Metabolic
      • Endocrine and Metabolic 1: Adrenal Crisis Portal
      • Endocrine and Metabolic 2: Diabetic Ketoacidosis Portal
      • Endocrine and Metabolic 3: Myxedma Coma (Severe Hypothyroidism) Portal
      • Endocrine and Metabolic 4: Thyroid Storm Portal (Severe Thyrotoxicosis/Hyperthyroidism)
      • Endocrine and Metabolic 5: Hyperosmolar (Hyperglycemic) Non-Ketotic State Portal
      • Endocrine and Metabolic 6: Acid-Base Portal Concepts and Clinical Considerations
      • Endocrine and Metabolic 7: Disorders of Electrolyte Concentration Portal
    • Section 15
      Environmental
      • Environmental 1: Hypothermia Portal
      • Environmental 2: Hyperthermia/Heat Stroke Portal
      • Environmental 3: Burns Management Portal
      • Environmental 4: Near Drowning Portal
      • Environmental 5: High Altitude Illness Portal
      • Environmental 6: Snake Bite Portal
    • Section 16
      Farming
      • Farming 1: Respiratory Illnesses Portal
      • Farming 2: Farm Wounds/Amputation Portal
      • Farming 3: Chemical Exposures Portal
    • Section 17
      Gastrointestinal/
      Abdominal
      • Gastrointestinal/Abdominal 1: Esophageal Varices Portal
    • Section 18
      Geriatrics
      • Geriatrics 1: General Aging Portal
    • Section 19
      Infection
      • Infection 1: Adult Pneumonia
      • Infection 2: Meningitis Portal
      • Infection 3: Sepsis in Adults Portal
      • Infection 4: Abdominal Sepsis Portal
      • Infection 5: Tetanus Immunization Status Portal
    • Section 20
      Neonatal
      • Neonatal 1: Neonatal Resuscitation Algorithm
      • Neonatal 2: Drugs in Neonatal Resuscitation
      • Neonatal 3: Meconium Suctioning Portal
      • Neonatal 4: Umbilical Artery and Vein Cannulation Portal
      • Neonatal 5: Inverted Triangle/Apgar Score Portal
      • Neonatal 6: Meningitis/Sepsis in Newborn Portal
      • Neonatal 7: Respiratory Distress Syndrome Scoring System Portal
    • Section 21
      Neurology
      • Neurology 1: Status Epilepticus Portal
      • Neurology 2: Stroke Portal
      • Neurology 3: NIH Stroke Scale Portal
      • Neurology 4: Phenytoin and Fosphenytoin Loading Portal
      • Neurology 5: Increased Intracranial Pressure Portal
    • Section 22
      Obstetrics
      • Obstetrics 1: Physiology of Pregnancy Portal
      • Obstetrics 2: Ultrasound Use Portal
      • Obstetrics 3: Bleeding in Early Pregnancy/Miscarriage Portal
      • Obstetrics 4: Dilatation and Curettage Portal
      • Obstetrics 5: Fetal Heart Tone Monitoring Portal
      • Obstetrics 6: Preterm Labor Management Portal
      • Obstetrics 7: Bleeding in the Second Half of Pregnancy Portal
      • Obstetrics 8: Hypertension In Pregnancy Portal
      • Obstetrics 9: Trauma in Pregnancy Portal
      • Obstetrics 10: Emergency Cesarean Section Portal
      • Obstetrics 11: Imminent Delivery Portal
      • Obstetrics 12: Malpresentations and Malpositions: Breech, Occiput Posterior Portal
      • Obstetrics 13: Assisted Delivery Portal
      • Obstetrics 14: Shoulder Dystocia Portal
      • Obstetrics 15: Third-stage and Postpartum Emergencies Portal
      • Obstetrics 16: Thromboembolic Disease and Pregnancy Portal
    • Section 23
      Pediatrics
      • Pediatrics 1: Physiologic and Anatomic Considerations Portal
      • Pediatrics 2: Tracheal Foreign Body Portal
      • Pediatrics 3: Epiglottitis Portal
      • Pediatrics 4: Laryngotracheal Bronchitis (Croup) Portal
      • Pediatrics 5: Bacterial Tracheitis Portal
      • Pediatrics 6: Bronchiolitis Portal
      • Pediatrics 7: Pneumonia Portal
      • Pediatrics 8: Sepsis Portal
      • Pediatrics 9: Meningitis Portal
      • Pediatrics 10: Diphtheria Portal
      • Pediatrics 11: Glasgow Coma Scale Portal
      • Pediatrics 12: Intraosseous Vascular Access
    • Section 24
      Sedation/
      Pain Control/
      Anesthesia
      • Sedation/Pain Control/Anesthesia 1: Procedural Sedation
      • Sedation/Pain Control/Anesthesia 2: Management of Combative, Agitated, Delirious Patients
      • Sedation/Pain Control/Anesthesia 3: Malignant Hyperthermia Portal
    • Section 25
      Toxicology
      • Toxicology 1: Systematic Approach
      • Toxicology 2: Essential Antidotes Portal
      • Toxicology 3: Acetaminophen Overdose Portal
      • Toxicology 4: Aspirin Overdose Portal
      • Toxicology 5: Tricyclic Antidepressants Overdose Portal
      • Toxicology 6: Beta Blocker Toxicity Portal
      • Toxicology 7: Calcium Channel Blocker Toxicity Portal
      • Toxicology 8: Bendodiazepine Overdose Portal
      • Toxicology 9: Alcohol Withdrawal Portal
      • Toxicology 10: Toxic Alcohols: Methanol and Ethylene Glycol
      • Toxicology 11: Cocaine Ingestion Portal
      • Toxicology 12: Narcotic Overdose Portal
      • Toxicology 13: Amphetamine Analog Intoxication Portal
      • Toxicology 14: Iron Ingestion Portal
      • Toxicology 15: Carbon Monoxide Poisoning Portal
      • Toxicology 16: Hyperbaric Oxygen and Normobaric Oxygen
      • Toxicology 17: Cyanide Poisoning Portal
      • Toxicology 18: Organophosphates Toxicity Portal
    • Section 26
      Trauma Care
      • Trauma Care 1: Shock Portal
      • Trauma Care 2: Shock Evaluation Overview Portal
      • Trauma Care 3: Use of Hemostatic Agents to Control Major Bleeding Portal
      • Trauma Care 4: Severe Traumatic Brain Injury—Adult 
      • Trauma Care 5: Severe Traumatic Brain Injury—Pediatric
      • Trauma Care 6: Compartment Syndrome
    • Section 27
      Tropical Medicine
      • Tropical Medicine 2: Introduction
      • Tropical Medicine 3: Fever and Systemic Manifestations
      • Tropical Medicine 4: Gastrointestinal and Abdominal Manifestations
      • Tropical Medicine 5: Dermatological Manifestations
      • Tropical Medicine 6: Muscular Manifestations (Including Myocardium)
      • Tropical Medicine 7: Neurological Manifestations
      • Tropical Medicine 8: Ocular Manifestations
      • Tropical Medicine 9: Pulmonary Manifestations
      • Tropical Medicine 10: Urogenital Manifestations
      • Tropical Medicine 11: Disorders of Nutrition and Hydration
      • Tropical Medicine 12: Medicine in Austere Environs
      • Tropical Medicine 13: Antiparasitic Primer
      • Tropical Medicine 14: Concise Parasitic Identification
      • Tropical Medicine 15: Bibliography
    • Section 28
      Ultrasound
      • Ultrasound 1: Emergency Ultrasound Applications Portal
      • Ultrasound 2: Emergency Ultrasound Techniques Portal

Print page

Tropical Medicine 4: Gastrointestinal and Abdominal Manifestations

As with fever, virtually any infection or noninfectious disease may present with nausea or other abdominal complaints. This chapter presents those diseases for which abdominal symptoms are the hallmark.

Bowel Trouble—Diarrhea and Dysentery

Cholera
Cholera is a bacterial infection that, via its toxin, causes severe diarrhea and death by water and electrolyte depletion. Cholera is spread via the fecal-oral route directly or through contamination of food and water. After an incubation period of just a few days, profuse, watery diarrhea develops. Fever is rare; hypoglycemia is common.

Diagnosis is clinical for severe cases; few other etiologies exist for this clinical picture. Mild cases may be misdiagnosed as rotavirus or other viral gastroenteritis. Microscopy (dark field) of stool in severe cases can aid in diagnosis, as can culture.

Treatment is based on rehydration. Initial rehydration may require rates of 4 L/h IV for adults with lactated Ringer’s the solution of choice. Once stabilized, ensuring that inflow equals loss (may be over 20 L/day) is essential. Use of glucose-electrolyte oral rehydration solution should replace IV fluids when the patient is able to maintain appropriate intake. Tetracycline (500 mg PO every 6 hours for 3 days), or doxycycline (300 mg PO once) may be helpful in severe cases, but should be avoided in mild forms to prevent resistance.

Traveler’s Diarrhea
This syndrome is common (affecting 50% to 70% of travelers) 1,2 and usually self-limiting. It presents as watery diarrhea, cramps, nausea, mild fever, and malaise. Traveler’s diarrhea is usually caused by enterotoxigenic Escherichia coli (E coli), but may also be due to Campylobacter, Salmonella, Shigella, and other bacterial pathogens as well as protozoan and viral agents.

Diagnosis is clinical. If prolonged or severe symptoms are present, consider additional diagnoses beyond simple traveler’s diarrhea.

To treat, hydrate the patient and administer the presumptive antibiotic ciprofloxacin (Cipro) 500 mg twice daily for 3 days (other quinolones may also be used for 3 days) or azithromycin 500 mg PO day 1, 250 mg PO day 2 through resolution of symptoms. Antimotility agents should not be given without also using antibiotics.

Tropical Sprue
Often following acute diarrheal illness, a malabsorption syndrome may develop. It is characterized by non-bloody diarrhea and steatorrhea, bloating, and weight loss. Duodenal biopsy shows villous atrophy similar to celiac sprue. The underlying mechanism is not known. The course may be prolonged with significant morbidity associated with it. Tetracycline and folic acid is often effective at reversing the symptoms.

Giardiasis
Giardia is a protozoan acquired by ingestion of cysts. This organism may produce a malabsorptive diarrhea manifest as explosive gas emissions and a remarkably foul odor. Often, the patient appears otherwise healthy.

Diagnosis is identification of the organism in the stool; serological and antigenic tests are also available.

Giardiasis responds well to metronidazole 500 mg twice daily for 5 days.

Coccidian Infections
Cryptosporidium, Cyclospora, Isospora, and Microspora are all protozoan parasites that cause prolonged watery diarrhea, cramps, fever, and fatigue. Often asymptomatic, they are of significance mainly for the immunocompromised.

Diagnosis is often missed. Identification of the organism in the stool is the mainstay. If suspected, specifically instruct the lab to look for these organisms.

Treatment is variable. Use paromomycin for HIV patients with cryptosporidiosis; Bactrim is effective for Isospora and Cyclospora.

Dysentery
Dysentery differs from diarrhea in that there is significant blood and mucous in the stools. This may be caused by a variety of organisms.

Bacterial
Shigellae is the most common cause of bacillary dysentery, and is acquired through the fecal-oral route. Following ingestion and an incubation of around a week, disease develops, ranging from (1) asymptomatic to (2) mild, self-limiting to (3) possibly fatal, fulminate gangrenous enterocholitis with serious blood loss, sepsis, and hemolytic uremic syndrome. Complications may include toxic megacolon, strictures, and even neuropathy and Reiter’s syndrome. In more severe cases, the stool is described as currant jelly in appearance, contains pus, and may number 20 to 60 per day.

Diagnosis is clinical, though culture may be helpful.

Management is primarily supportive, especially in regard to fluid and electrolytes. Blood transfusion and dialysis may be required in some cases. Drug resistance is common, and quinolones or macrolides may be used in more severe cases. There is some evidence, however, that use of antibiotics in children may increase risk of development of HUS (hepatic uremic syndrome).

Enterohemorrhagic E coli O157:H7 is similar in presentation, course, and treatment.

Protozoan

Amoebic dysentery, caused by Entamoeba histolytica, is acquired through ingestion of the cysts. Incubation ranges from days to years, and the majority of infections remain asymptomatic. Invasive colitis seems to be triggered by other infection or immunocompromise. Onset of symptoms is insidious and variable in severity. Fever is uncommon. Complications may include peritonitis, hemorrhage, ulcerative colitis, extra-intestinal abscess formation, or an amoeboma (a mass of granulation tissue arising from a localized colonic infection), which may present as a tender palpable mass, bowel obstruction, or intussusception.

Diagnosis is identification of the organism in the stools. Serology, antigenic and DNA testing, and endoscopy may be helpful.

A 5-day course of metronidazole 500 mg twice daily is often adequate to treat dysentery. Extralumenal abscesses require more aggressive treatment.

Helmintic
The geohelminth, Trichuris, may present with a dysentery-like clinical picture, occasionally associated with rectal prolapse. It is acquired via the fecal-oral route. Diagnosis is by identification of the ova or the worms in the stool, and treatment with a single dose of mebendazole 500 mg PO (100 mg PO twice daily for 3 days in severe cases).

Bowel Trouble—Parasites

Parasitic infestation may manifest itself as diarrhea, constipation, abdominal mass, or a combination of the above; thus they will be presented by organism rather than symptom.

Ascariasis
The life cycle of Ascaris explains its clinical presentations, and is worth reviewing. In addition, it serves as a representative of the other geohelminths.

The nematode parasite is acquired via the fecal-oral route. Its ova can persist in the environment for extended periods of time. Once within the human host, the larvae emerge and migrate to the lungs where they undergo maturation steps. They are then coughed up in phlegm; if this is swallowed, they complete their maturation back in the digestive tract. (See figure.) Adult worms are pencil-sized, and their eggs pass in the stool to the next host.

5_tm_4_A

Clinical manifestations may include significant pulmonary symptoms and asthma as the result of these highly allergenic larvae passing through the lungs. The adult worms may form large tangled boluses in the bowel, obstructing it; they may also obstruct the biliary tree and present as colicky pain, or even migrate out of the digestive system and trigger sepsis by the bowel flora.

Diagnosis is via identification of the ova in stool samples; occasionally, larvae may be seen in sputum samples as well. Adult worms may be passed per rectum and can be as long as 6 to 8 inches.

Ivermectin, mebendazole, and thiabendazole are used in treatment (see Vol III—TM13 Antiparasitic Primer).

Hookworms
Hookworms have a lifecycle similar to that of Ascaris, with the notable exception that, rather than being acquired through the ingestion of ova, its ova “hatch” in the soil, and the larvae penetrate the new host’s bare foot from which they migrate to the lungs and ultimately the bowel. There, instead of absorbing nutrients in competition with the host, it latches on and sucks its blood.

Pulmonary and gastrointestinal manifestations of this infestation are less common than ascariasis. Rather, severe microcytic hypochromic anemia is the symptom most often recognized.

Diagnosis is identification of the ova in the stool, and treatment is similar to that for ascariasis.

Strongyloidiasis
This geohelminth is acquired through the skin like hookworms, only it doesn’t cause anemia, instead competing with its host for nutrients like Ascaris.

Again, pulmonary or gastrointestinal symptoms are unusual. However, these worms are prone to venture beyond the lumen of the bowel and trigger a polymicrobial sepsis (that prompts the astute clinician to order a stool specimen for ova and parasites). Diagnosis is visualization of the worms on microscopy. It is the only human helminth normally passed as live worms, not ova, in the stool (if the stool specimen is not fresh, hookworm ova may hatch, and their larvae will mislead the microscopist into misdiagnosing the worm).

Treatment agents mirror those used for Ascaris.

Pinworm
These worms are acquired by the ingestion of ova from the environment. They hatch and the larvae mature in the bowel. Adult worms then migrate out the anus, adhering their ova to the perianal skin before returning from whence they came. As the adhesive dries, the eggs slough off and may be carried throughout the house on air currents.

The main clinical symptom is severe pruritis ani, resulting from the allergenic worm slime used to adhere the eggs in place. Diagnosis is by tape test, whereby Scotch tape is stuck to the perianal region and then gently removed, placed on a microscope slide, and examined. Treatment is mebendazole or ivermectin.

Tapeworm
Tapeworms have a lifecycle that includes both tissue- and lumen-dwelling stages. The host acquires the tapeworm by ingesting meat containing the tapeworm cysts (cysticerci). From this, the adult worm develops within the bowels, producing many packets of eggs (proglottids), which are passed in the stool while the head (scolex) remains embedded within the host. The second host acquires cysticerci by ingesting eggs. This cycle typically involves passing the parasite between a herbivore and its predator. (See figure.)

5_tm_4_B

Taenia are parasites of domestic cattle and pigs. Humans may acquire the tapeworms by eating undercooked meat. Clinical symptoms are nonspecific, and infection is usually recognized after passing proglottids in the stool. Treatment of the tapeworm stage is the use of praziquantel (Vol III—TM13 Antiparasitic Primer). If humans ingest the ova, cysticercosis develops (Vol III—TM6 Muscular Manifestations), which is most serious if the cysticerci develop within the central nervous system (Vol III—TM7 Neurological Manifestations).

Ecchinococcus normally infects dogs and sheep (or other canine-predator-prey relationships such as wolves, deer, coyotes, and dingos). These organisms form hydatid cysts instead of cysticerci when humans are infected. These large cysts, in contrast to cysticerci, cause trouble wherever they form. Though they may affect the central nervous system, they are most commonly seen intra-abdominally. They generally present as rapidly growing masses. Ultrasonography and other imaging modalities are useful in the diagnosis. Treatment is challenging, for surgical excision is complicated by the fact that the contents of the cyst are highly allergenic and can trigger anaphylactic reactions if spilled intraoperatively. In addition, the hydatid sand includes brood capsules, which may form multiple new cysts if they are spilled. Albendazole has been shown to be reasonably effective medical therapy.

Diphyllobothrium is acquired by ingesting cysticerci in fish and may grow to extraordinary lengths. It is significant in that its tremendous surface area competes for vitamin B12 and its clinical presentation may well be pernicious anemia. Diagnosis is identification of ova in stool. Praziquantel is the agent of choice.

Other tapeworms may affect humans, including Dipylidium, and Hymenolepis, but are usually asymptomatic and self-limiting.

Biliary Trouble—Jaundice, Hepatomegaly, or Colic

Viral Hepatitis
Acute viral hepatitis A, B, D, and E are virtually indistinguishable clinically (acute hepatitis C is usually so mild that care isn’t sought). Jaundice, nausea, vomiting, and malaise are common, and ascites and coagulopathies may occur. The food- and water-borne hepatitis A and E have no long-term consequences, but the body-fluid-borne hepatitis B, C, and D do.

Diagnosis of viral hepatitis is clinical; distinguishing the particular type relies on serological studies. No drugs have demonstrated efficacy in treatment of acute viral hepatitis, and treatment is supportive. Pharmacological intervention in chronic viral hepatitis may be beneficial, but is beyond the scope of this chapter.

Kala-Azar
Visceral leishmaniasis is a protozoan parasitic infection transmitted by the sand fly bite. The promastigote form injected by the bite is phagocytized by macrophages in which they convert to amastigotes and multiply by binary fission. This infection is also called dumdum fever. (See Vol III—TM5 Dermatological Manifestations).

Clinically, the onset is insidious with low-grade fever, hepatosplenomegaly, and anorexia. Low-grade abdominal pain may develop as the result of splenic infarcts. Fatality is up to 50% in treated patients and 90% in those untreated.3

Serological tests are useful in diagnosis, as is demonstration of the intramacrophagal amastigotes in splenic aspirates, bone marrow, buffy coat, or lymph nodes.

Treatment consists of toxic drugs, see Vol III—TM13 Antiparasitic Primer Noteworthy is the occurrence of post-kala-azar dermatitis in 10% of patients following treatment.3 Initially a maculopapular rash, this may progress to the appearance of lepromatous leprosy and may last many years. Longer courses of pentavalent antimonials may be necessary to clear this up.

Liver and Bile Flukes
Fasciola, Opisthorchis, and Clonorchis are acquired by consuming the infective metacercarial cysts on raw vegetable (watercress), upon which they were deposited by snails. These trematodes mature and migrate to the liver and bile ducts. Acute symptoms include fever, fatigue, abdominal pain, anorexia, and respiratory symptoms. Chronically, recurrent biliary colic may be present, as can hepatomegaly, and in heavy infections, bleeding into the biliary system may result.

Diagnosis is the identification of ova in the stool; serological tests are also available, and a fecal antigen test looks promising.

Praziquantel readily treats these infections.

Visceral Larval Migrans

Toxocara, an infection of dogs and cats, may infect humans, though they do not mature beyond the larval stage in the wrong host. Acquired via the fecal-oral route (imagine children playing in the sandbox), the larva migrate, searching unsuccessfully for their proper habitat. As they migrate, they cause local damage and elicit significant host responses. Pneumonitis, myalgia, hepatosplenomegaly, and neuropsychiatric disturbances may occur, depending on the tissue through which the larvae are passing.

Diagnosis is via serology (or clinical, especially in the case of cutaneous larval migrans); a variety of anthelmintics are effective. (See Vol III—TM13 Antiparasitic Primer).

Schistosomiasis, also known as bilharziasis, causes substantial morbidity throughout the world. The larval form, cercariae, is shed by freshwater snails (who in turn were infected by metacercariae-hatched eggs passed in human feces). These penetrate the skin of their swimming or wading host and migrate to the liver by way of the lungs, and ultimately the mesenteric veins (or bladder plexus in the case of Schistosoma haematobium [S haematobium], which will be discussed in Vol III—TM10 Urogenital Manifestations. There, they lay eggs in terminal venules, which slowly erode their way to the lumen of the bowels and are passed in the feces.

Acute illness may include swimmer’s itch from the invasion of the cercariae, and Katayama fever (fever, urticaria, eosinophilia, diarrhea, hepatosplenomegaly, bronchospasms, and cachexia). Chronically, the constant irritation may lead to pseudopolyposis of the colon. Of greatest significance is Symmers’ pipestem fibrosis, which is the result of the countless eggs which get swept away by circulation into the liver rather eroding to the bowels. The granulomatous reaction to this leads to portal hypertension with sparing of hepatocellular function (until the very end) and presents with hepatosplenomegaly, esophageal varices, and caput medusae. Occasionally, the worms may wander and conditions such as neuroschistosomiasis may develop.

Diagnosis is identification of the ova in sedimented stool (not just a smear), or in rectal biopsy. It is important to wait an adequate period (3 months) for egg-laying to begin. Serological testing is not reliable.

The treatment of choice is praziquantel; once the egg-laying ceases, the granulomas tend to regress.

Yellow Fever
Covered in TM3 (Vol III—TM3 Fever and Systemic Manifestions), yellow fever got its name for the jaundice it produces.

Ascariasis
Covered earlier in this chapter, these large worms may cause biliary obstruction.

Cancer
Neoplasms may also cause symptoms referable to the hepatobiliary system. Of significance, cancer of the gall bladder is associated with the carrier state in typhoid, and risk for cholangiocarcinoma is increased in the setting of infection by bile flukes.

Other Causes
A variety of other infectious diseases may cause jaundice, including leptospirosis, Q fever, and malaria, all of which were discussed in the previous chapter.

Another potential cause of jaundice is mildly (or not mildly) hepatotoxic or cholestatic traditional herbal medicines or teas used abroad. Although this cause is relatively common among the locals, it is less common among expatriates and is discovered by taking a complete history. Not only traditional medicines, but also the Western medicines prescribed for travelers may cause liver enzyme anomalies (eg, mefloquine, acetaminophen).

References

  1. Steffen R, Lobel HO. Epidemiological basis for the practice of travel medicine. J Wilderness Med. 1994;4:56-66.
  2. Castelli F, Saleri N, Tomasoni LR, Carosi G. Prevention and treatment of travelers’ diarrhea. Digestion. 2006;73:109-118.
  3. Gill GV, Beeching NJ. Lecture notes in tropical medicine, 5th ed. Malden, MA: Blackwell Science, 2004.
Edition 13-October 2011

Copyright©CALS. Comprehensive Advanced Life Support | © 2012 CALS Program